chinese semaglutide GLP-1 Weight-Loss Drug Matches Novo Nordisk's in Efficacy Ascletis Pharma trial shows drug

UAN: 0430-0000-19-106-H01-P Credits: 2.0 hours (0.20 ceu) Type of Activity: Knowledge TARGET AUDIENCE: This accredited activity is targeted to pharmacists

[corrected] SGLT-2 inhibitors and GLP-1 receptor agonists are associated with similar weight loss

The cycling approach alternates treatment periods with break periods, typically following patterns like 3-4 months on followed by 1-2 months off, 6 months on followed by 2-3 months off, or flexible cycling based on skin condition assessment and benefit plateau timing

Understanding this distinction matters for patients considering both dietary and pharmacological approaches to metabolic health

Semaglutide in GLP-1 combination products The GLP-1 medication category continues to expand, with new formulations and combination products entering the market

If you are ready to try peptides for weight loss, get started by using our virtual consultation tool or by scheduling an appointment online.